What We're Reading: Page 8
Industry reads hand-picked by our editors
Aug 11, 2025
Aug 08, 2025
-
The Wall Street Journal
The Race to Find a Measles Treatment as Infections Surge
-
Reuters
Trump, pharma industry discuss boosting medicine spending abroad
-
Bloomberg Law
Boehringer Fails to Revive Suit Over US Drug Price Negotiations
Aug 07, 2025
-
Financial Times
Novartis weighs deal for biotech Avidity to boost drug pipeline
-
Reuters
Struggling US healthcare stocks endure rough 2025 but draw some bargain hunters
-
BioSpace
Bayer Expects More Layoffs To Come Following a Brutal Two Years of Cost-Cutting
-
KFF Health News
Patient Numbers at NIH Hospital Have Plummeted Under Trump, Jeopardizing Care
Aug 06, 2025
-
Bloomberg
Amgen Boosts 2025 Guidance After Beating Wall Street Estimates
-
Financial Times
Sandoz targets 70% price cut for weight-loss drugs in Canada
-
MedTech Dive
Medical device industry says future MDUFA hikes unsustainable
-
The New Yorker
How to Live Forever and Get Rich Doing It
Aug 05, 2025
Aug 04, 2025
-
The Wall Street Journal
How Trump’s ‘Big Beautiful Bill’ Will Keep Drug Prices Higher Longer and Cost Medicare Billions
-
Stat News
FDA’s top cancer drug regulator played key role in rejection of Replimune therapy
-
MedTech Dive
Heartflow prices IPO, aiming to net about $180M
-
The Washington Post
There’s another risk to your heart that’s getting new attention
Aug 01, 2025
-
The Washington Post
Medicare, Medicaid to experiment with covering weight loss drugs
-
BioSpace
Merck’s $3B Savings Push Claims 6,000 Jobs
-
Financial Times
Switzerland in ‘shock’ at 39% US tariff blow
Previous
